Chronos Therapeutics ^Companies

Chronos Therapeutics is a drug development company that focuses on developing drugs for age-related diseases. They have two main areas of focus: repositioning FDA approved drugs and screening, discovering, and developing novel proprietary drug candidates. Their current targets include diseases of aging such as osteoporosis, cancer, and sarcopenia, as well as neurodegenerative diseases like Parkinson's disease, Alzheimer's disease, ALS, and orphan synucleopathies. Chronos Therapeutics is advancing their research from pre-clinical stages to clinical development and their pioneering drug discovery and development platform, the Chronoscreen, has allowed them to gain proprietary positions in the regulation of cellular chronological lifespan. Their goal is to harness the knowledge of biological programming of lifespan and aging to develop novel treatments for age-related diseases.